NCT00189735View on ClinicalTrials.gov

A Study to Evaluate FK778 in Kidney Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Kidney TransplantationRenal TransplantationTransplantation, RenalTransplantation, KidneyGrafting, Kidney
Interventions
DRUG

FK778

Trial Locations (37)

1070

Brussels

1200

Brussels

3000

Leuven

6020

Innsbruck

6202

Maastricht

8091

Zurich

10117

Berlin

10126

Torino

13353

Berlin

14004

Córdoba

14021

Prague

28034

Madrid

28041

Madrid

34295

Montpellier

35003

Rennes

35128

Padua

39008

Santander

42055

Saint-Etienne

45122

Essen

46009

Valencia

60590

Frankfurt

75185

Uppsala

81675

München

93053

Regensburg

94010

Créteil

94275

Le Kremlin-Bicêtre

29 200

Brest

Unknown

Grenoble

31 403

Toulouse

06112

Halle

00168

Roma

85-094

Bydgoszcz

70-111

Szczecin

08025

Barcelona

08036

Barcelona

08907

Barcelona

M13 9WL

Manchester

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00189735 - A Study to Evaluate FK778 in Kidney Transplant Patients | Biotech Hunter | Biotech Hunter